7/2/2025API China 2025 Ends with High Attendance and Global Industry Participa...

7/2/2025China to Eliminate CD Submission Requirement for Clinical Trial Databa...

7/2/2025China Issues Technical Guidance for Clinical Resistance Studies of Ant...

7/2/2025HanchorBio and Henlius Ink Major Licensing Deal for I/O Candidate HCB1...

7/2/2025InventisBio Launches First Phase III Trial of TYK2 Inhibitor D‑2570 i...

7/2/2025Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...

7/2/2025NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...

7/2/2025China Grants Conditional Approval to Bebetter Medicine's Ifupinostat f...

7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...

7/2/2025Biokin's Iza-bren Achieves Primary Endpoint in Phase III Trial for Nas...

7/1/2025Record China Pharma Monopoly Fine Sends Strong Deterrent Signal, Exper...

More>>

7/2/2025FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...

7/2/2025Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)

7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...

7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...

7/1/2025China Launches Landmark Measures to Boost Innovative Drug Industry, Se...

6/27/2025Analyzing Key Trends in China's Patent-Linkage System and Their Impact...

6/27/2025Fresh Antitrust Guidelines to Address Pharmaceutical Monopoly Issues i...

6/25/2025Breaking the Boundaries: A New Map of Physician Behavior in China's Di...

6/19/2025Structuring Cross Border China Biotech 'NewCo' Transactions (Life Scie...

6/19/2025CDE Annual Report Reveals Strong Growth and Evolving Focus in China's ...

6/17/2025China Emerges as Prime Global Target for Multinationals in Biotech Dea...

More>>